Production (Stage)
Claritas Pharmaceuticals, Inc.
CLAZF
$0.00
$0.000.00%
OTC PK
| 09/30/2021 | 06/30/2021 | 03/31/2021 | 12/31/2020 | 09/30/2020 | |
|---|---|---|---|---|---|
| Net Income | 181.00K | -1.94M | -2.30M | -654.00K | -413.00K |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 318.00K | 1.13M | 2.61M | 185.00K | 1.50M |
| Change in Net Operating Assets | -780.00K | 955.00K | -631.00K | -15.00K | -818.00K |
| Cash from Operations | -281.00K | 136.00K | -324.00K | -484.00K | 267.00K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -1.00K | 0.00 |
| Cash from Investing | -- | -- | -- | -1.00K | 0.00 |
| Total Debt Issued | 0.00 | 118.00K | -- | 0.00 | 0.00 |
| Total Debt Repaid | 0.00 | 0.00 | -10.00K | -- | -- |
| Issuance of Common Stock | 1.00K | 0.00 | 357.00K | 0.00 | 212.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.00K | 118.00K | 347.00K | 0.00 | 212.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -280.00K | 254.00K | 23.00K | -485.00K | 479.00K |